Onkologische Notfälle

  • H.-J. Schmoll
  • H.-D. Peters


Im Verlauf von Tumorerkrankungen und im Rahmen von antineo-plastischen Therapien bei Tumorerkrankungen kann es zu Notfallsituationen kommen, die das Leben des Patienten gefährden. Insbesondere bei kurativ behandelbaren Tumoren ist die frühe Erkennung und Diagnose der Notfallsituation ebenso wichtig wie die rasche adäquate Behandlung.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahmann FR (1984): A reassessment of the clinical implications of the superior vena cava syndrome. J Clin Oncol 2:961–969PubMedGoogle Scholar
  2. Betrand M et al (1984): Iatrogenic superior vena cava syndrom. A new entity. Cancer 54:376–378CrossRefGoogle Scholar
  3. Davenport D, Ferree C, Blake D, Raben M (1978): Radiation therapy in the treatment of superior vena cava obstruction. Cancer 42:2600–2603PubMedCrossRefGoogle Scholar
  4. Lockich JJ, Becker B (1983): Subclavian Vein Thrombosis in Patients treated with Infusion for Advanced Malignancy. Cancer 52:1586–1589CrossRefGoogle Scholar
  5. Lockich JJ et al (1985): Complications and management of implanted venous access catheters. J Clin Oncol 3:710–717Google Scholar
  6. Loeffler JS, Leopold KA, Recht A, Weinstein HJ, Torbell NJ (1986): Emergency Prebiopsy Radiation for Mediastinal Masses: Impact on Subsequent Pathologic Diagnosis and Outcome. J Clin Oncol 4:716–721PubMedGoogle Scholar
  7. Marsha GW (1982): Superior vena cava syndrome and other obstructive syndroms. In: Skeel (Hrsgb.) Manual of cancer chemotherapy, 1st edn. Little, Brown, Boston, pp 213–214Google Scholar
  8. Perez CA et al (1978): Management of superior-vena-cava-syndrome. Semin Oncol 5:123–134PubMedGoogle Scholar
  9. Perez-Soler R, McLaughlin P, Velasquez et al (1984): Clinical features and results of management of superior vena cava syndrome, secondary to lymphoma. J Clin Oncol 4:260–266Google Scholar
  10. Rubin P et al (1963): Superior-vena-cava-syndrome. Radiology 81:388–401PubMedGoogle Scholar
  11. Sculier JP, Feld R (1985): Superior vena cava obstruction syndrome. Cane Treat Review 12:209–218CrossRefGoogle Scholar
  12. Schwartz EE, Goodman LR, Haskin ME (1986): Role of CT-Scanning in the Superior Vena Cava Syndrome. Am J Clin Oncol (CCT) 9 (1): 71–78CrossRefGoogle Scholar
  13. Sculier JP et al (1986): Superior Vena Cava Obstruction Syndrome in Small Cell Lung Cancer. Cancer 57: 847–851PubMedCrossRefGoogle Scholar
  14. Silverstein GE (1969): Superior-vena-cava-system-obstruction caused by benign endothoracic gouiter. Dis Chest 56:519ffCrossRefGoogle Scholar
  15. Au W (1975) Calcitonin treatment of hypercalcemia due to parathyroid carcinoma-synergistic effect of prednisone on long-term treatment of hypercalcemia. Arch Intern Med 135:1594–1597PubMedCrossRefGoogle Scholar
  16. Breuer RI, LeBauer J (1967) Caution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab 97:695–698CrossRefGoogle Scholar
  17. Van Breukelen FJM, Bijvoet PLM, Van Oosterom AT (1979) Inhibition of osteolytic bone lesions by (3-amino-l-hydroxyprophylidene)-l, 1-diphos-phonate (ADP). Lancet 1:803–805PubMedCrossRefGoogle Scholar
  18. Elias EG, Evans JT (1972) Hypercalcemic crisis in neoplastic diseases. Management with mithramycin. Surgery 71:631–635PubMedGoogle Scholar
  19. Fields ALA, Josse RG, Bergsagel DE (1985) Metabolic emergencies. In: De Vita Jr VT, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology. Lippincott, Philadelphia Toronto, pp 1866–1872Google Scholar
  20. Lazor MZ, Rosenberg LE (1964) Mechanism of adrenal-steroid reversal of hypercalcemia in multiple myeloma. N Engl J Med 270:749–755PubMedCrossRefGoogle Scholar
  21. Krane SM, Harris ED Jr, Singer et al (1973) Acute effects of calctonin on bone formation in man. Metabolism 22:51–58PubMedCrossRefGoogle Scholar
  22. Muggia FM, Heinemann HO (1970) Hypercalcemia associated with neoplastic disease. Arch Intern Med 73:281–290Google Scholar
  23. Perlia CP, Gubisch NJ, Wolter J et al (1970) Mithramycin treatment of hypercalcemia. Cancer 25:389–394PubMedCrossRefGoogle Scholar
  24. Seyberth HW, Segre GV, Morgan JL et al (1975) Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med 293:1278–1283PubMedCrossRefGoogle Scholar
  25. Siris ES, Sherman WH, Baguiran DC et al (1980) Effects of dichlormethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. N Engl J Med 302:310–315PubMedCrossRefGoogle Scholar
  26. Suki WN, Yium JJ, Minden M von et al (1970) Acute treatment of hypercalcemia with furosemide. N Engl J Med 283:836–840PubMedCrossRefGoogle Scholar
  27. Vaughn CB, Vaitkevicius K (1974) The effects of calcitonin in hypercalcemia in patients with malignancy. Cancer 34:1268–1271PubMedCrossRefGoogle Scholar
  28. Warrel RP et al (1986) Gallium nitrate for acute treatment of cancer related hypercalcemia: clinicopharmacologic and dose-response analysis. Proc Am Soc Clin Oncol 5:112Google Scholar
  29. Brady LW et al (1975) The treatment of metastatic disease of the nervous system by radiation therapy In: Seydel HD (ed) Tumors of the nervous system. Wiley & Sons, New York, pp 177–188Google Scholar
  30. Brucknan JE, Bloomer WD (1979) Management of spinal cord compression. Semin Oncol 5:135–140Google Scholar
  31. Friedman M et al (1976) Spinal cord compression in malignant lymphoma. Cancer 37:1485PubMedCrossRefGoogle Scholar
  32. Gilbert RW et al (1978) Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment. Ann Neurol 3:40PubMedCrossRefGoogle Scholar
  33. Graus F et al (1985) Early diagnosis of spinal epidural metastasis (SEM): Correlation with cinical and radiologic findings. Proc ASCO 4:269Google Scholar
  34. Hall AJ, Mackay NNS (1973) The results of laminectomy for compression of the cord and cauda-equina by extradural malignant tumor. J Bone Joint Surg 55:497–505Google Scholar
  35. Maced N et al (1985) Decompressive laminectomy for metastatic carcinoma: What are the current indications? Proc ASCO 4:278Google Scholar
  36. O’Rourke T et al (1985) Spinal CT scanning and CT metrizamide myelography in the detection of spinal bone and epidural metastasis. Proc ASCO 4:7Google Scholar
  37. Siegal T et al (1985) Experimental malignant compression of the spinal cord: failure of effective systemic chemotherapy to prevent paraplegia. Proc Am Soc Clin Oncol 4:129Google Scholar
  38. Sundaresan N et al (1984) Vertebral body resection in the treatment of cancer involving the spine. Cancer 53:1393–1396PubMedCrossRefGoogle Scholar
  39. Törmä T (1975) Malignant tumors of the spina and the spinal extradural space. A study based on 250 histologically verified cases. Acta Chir Scand [Suppl] 255:1–138Google Scholar
  40. Weissman DE, Gilbert E, Wang H, Grossman SA (1985) The use of computed Tomography of the Spine to Identify Patients at High Risk for Epidural Metastases. J Clin Oncol 3:1541–1544PubMedGoogle Scholar
  41. White WA et al (1971) Role of surgery in the treatment of spinal cord compression by metastatic neoplasm. Cancer 27:558PubMedCrossRefGoogle Scholar
  42. Clarkson DR et al (1973) Metabolism 22:611 ffCrossRefGoogle Scholar
  43. Cohen LF et al (1980) Am J Med 68:486 ffCrossRefGoogle Scholar
  44. Dalla-Favera R et al (1983) Science 219:963 ffCrossRefGoogle Scholar
  45. Tsokos GC et al (1981) Medicine 60:218 ffCrossRefGoogle Scholar
  46. Vogelzang NJ et al (1983) JAMA 249:513 ffCrossRefGoogle Scholar
  47. Ziegler JL (1981) Burkitt’s lymphoma. N Engl J Med 305:735 ffCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • H.-J. Schmoll
  • H.-D. Peters

There are no affiliations available

Personalised recommendations